undamentalytics Newsletter
Sign in

Treace Medical Concepts, Inc. revenue

Treace Medical Concepts, Inc.'s revenue was $213m in fiscal 2025, up 1.6% on the year before. Since fiscal 2019 ($39.4m) it has grown at a compound 32.4% a year. Over the last twelve months it was $205m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue395794142187209213205
Growth on the year before—+45.5%+64.6%+50.2%+31.9%+11.9%+1.6%—
Gross profit324578116152168170163
Gross margin80.6%78.3%82.1%82.0%81.2%80.4%79.8%79.5%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Treace Medical Concepts, Inc. $205m -4.0% 7.1%
Si-bone, Inc. $214m 15.3% 19.7%
Lakeland Industries Inc $191m -0.3% 17.0%
Establishment Labs Holdings Inc. $246m 38.6% 11.5%
Cerus Corp $254m 74.6% 89.8%
Lemaitre Vascular Inc $262m 11.8% 14.0%

Compare with peers

Head to head: SIBN vs TMCILAKE vs TMCIESTA vs TMCI

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Treace Medical Concepts, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Treace Medical Concepts, Inc.